Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment Strategy With High-dose Dexamethasone Versus Standard Dose in Patients With SARS-CoV-2 Pneumonia (COVID-19). PREDEXACOV Study

NCT05293210 is registered in ClinicalTrials.gov with Hospital Universitario Infanta Leonor as lead sponsor.

NCT NCT05293210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment Strategy With High-dose Dexamethasone Versus Standard Dose in Patients With SARS-CoV-2 Pneumonia (COVID-19). PREDEXACOV Study
Lead sponsor
Hospital Universitario Infanta Leonor
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2023
Completion date
December 1, 2023
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, dexamethasone